Literature DB >> 14688138

Stable T-cell population expressing an effector cell surface phenotype in the lungs of mice chronically infected with Mycobacterium tuberculosis.

Ana Paula Junqueira-Kipnis1, Joanne Turner, Mercedes Gonzalez-Juarrero, Oliver C Turner, Ian M Orme.   

Abstract

Analysis of T-cell subsets accumulating in the lungs of C57BL/6 mice chronically infected with Mycobacterium tuberculosis revealed that both CD4 and CD8 T-cell populations expressed a cell surface phenotype consistent with that of effector T cells and that a significant proportion of these cells were in the process of secreting gamma interferon.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688138      PMCID: PMC343994          DOI: 10.1128/IAI.72.1.570-575.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

Review 1.  A fatal attraction: Mycobacterium tuberculosis and HIV-1 target DC-SIGN to escape immune surveillance.

Authors:  Yvette van Kooyk; Ben Appelmelk; Teunis B H Geijtenbeek
Journal:  Trends Mol Med       Date:  2003-04       Impact factor: 11.951

Review 2.  Mechanisms of latency in Mycobacterium tuberculosis.

Authors:  N M Parrish; J D Dick; W R Bishai
Journal:  Trends Microbiol       Date:  1998-03       Impact factor: 17.079

3.  Evolution of CD4 T-cell subsets following infection of naive and memory immune mice with Mycobacterium tuberculosis.

Authors:  J P Griffin; I M Orme
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 4.  The protective immune response to Mycobacterium tuberculosis.

Authors:  A M Cooper; J L Flynn
Journal:  Curr Opin Immunol       Date:  1995-08       Impact factor: 7.486

5.  Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.

Authors:  M C Raviglione; D E Snider; A Kochi
Journal:  JAMA       Date:  1995-01-18       Impact factor: 56.272

6.  Global tuberculosis incidence and mortality during 1990-2000.

Authors:  P J Dolin; M C Raviglione; A Kochi
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

Review 7.  The mouse as a useful model of tuberculosis.

Authors:  I M Orme
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131

8.  Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis.

Authors:  E R Rhoades; A A Frank; I M Orme
Journal:  Tuber Lung Dis       Date:  1997

Review 9.  T cell response to Mycobacterium tuberculosis.

Authors:  I M Orme; P Andersen; W H Boom
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

10.  Disseminated tuberculosis in interferon gamma gene-disrupted mice.

Authors:  A M Cooper; D K Dalton; T A Stewart; J P Griffin; D G Russell; I M Orme
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  22 in total

1.  Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis.

Authors:  Marcela Henao-Tamayo; Andrés Obregón-Henao; Elizabeth Creissen; Crystal Shanley; Ian Orme; Diane J Ordway
Journal:  Clin Vaccine Immunol       Date:  2014-11-12

2.  CD4 T cells producing IFN-gamma in the lungs of mice challenged with mycobacteria express a CD27-negative phenotype.

Authors:  I V Lyadova; S Oberdorf; M A Kapina; A S Apt; S L Swain; P C Sayles
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

3.  Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein.

Authors:  Scott M Irwin; Angelo A Izzo; Steven W Dow; Y A W Skeiky; Steven G Reed; Mark R Alderson; Ian M Orme
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Memory T lymphocytes generated by Mycobacterium bovis BCG vaccination reside within a CD4 CD44lo CD62 ligand(hi) population.

Authors:  Andre Kipnis; Scott Irwin; Angelo A Izzo; Randall J Basaraba; Ian M Orme
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

5.  In vivo adaptation of the Wayne model of latent tuberculosis.

Authors:  Lisa Woolhiser; Marcela Henao Tamayo; Baolin Wang; Veronica Gruppo; John T Belisle; Anne J Lenaerts; Randall J Basaraba; Ian M Orme
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

6.  Tuberculosis vaccines: current progress.

Authors:  Ian M Orme
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Humanized NOG mice as a model for tuberculosis vaccine-induced immunity: a comparative analysis with the mouse and guinea pig models of tuberculosis.

Authors:  Ajay Grover; Amber Troy; Jenny Rowe; JoLynn M Troudt; Elizabeth Creissen; Jennifer McLean; Prabal Banerjee; Gerold Feuer; Angelo A Izzo
Journal:  Immunology       Date:  2017-06-19       Impact factor: 7.397

8.  Interleukin-10 production by lung macrophages in CBA xid mutant mice infected with Mycobacterium tuberculosis.

Authors:  Ana Paula Junqueira-Kipnis; Andre Kipnis; Marcela Henao Tamayo; Marisa Harton; Mercedes Gonzalez Juarrero; Randall J Basaraba; Ian M Orme
Journal:  Immunology       Date:  2005-06       Impact factor: 7.397

9.  Effector memory Th1 CD4 T cells are maintained in a mouse model of chronic malaria.

Authors:  Robin Stephens; Jean Langhorne
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

10.  Intrapulmonary delivery of XCL1-targeting small interfering RNA in mice chronically infected with Mycobacterium tuberculosis.

Authors:  Adrian G Rosas-Taraco; David M Higgins; Joaquín Sánchez-Campillo; Eric J Lee; Ian M Orme; Mercedes González-Juarrero
Journal:  Am J Respir Cell Mol Biol       Date:  2008-12-18       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.